Article

Accommodating IOL receives NTIOL classification

An accommodating IOL with aspheric optics (Crystalens AO, Bausch + Lomb) has received new-technology IOL classification from the Centers for Medicare and Medicaid Services.

Aliso Viejo, CA

-An accommodating IOL with aspheric optics (Crystalens AO, Bausch + Lomb) has received new-technology IOL (NTIOL) classification from the Centers for Medicare and Medicaid Services (CMS).

The classification became effective April 9 and means that the lens is approved for an additional $50 Medicare payment adjustment for services in conjunction with cataract procedures performed at ambulatory surgical centers.

“We are pleased that the [lens] has been included into the active NTIOL class for reduced spherical aberration,” said Andy Corley, global president, Surgical, Bausch + Lomb. “We believe that this decision should benefit surgeons and their patients in the coming months."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.